High Purity Health Supplement Polymyxin B Sulphate CAS No. 1405-20-5

Min.Order: 25
Product origin: Wuhan, Hubei, China
Infringement complaint: complaintComplaint
US$ -1

Description
High Purity Health Supplement Polymyxin B Sulphate CAS NO.1405-20-5 


PRODUCT DETALS
 
ItemsSpecificationsResult
AppearanceWhite or almost white powder,hygroscopic.Conforms
SolubilitySoluble in water.slightly soluble in alcohol.Conforms
ldentificationA:The retention times of the major peaks from thesample solution correspond to 'those of thestandard solution,as obtained in the test forcomposition of Polymyxins.
B: To the sample solution add 5ml of 2.5N sodiumhydroxide,and mix,Add 5 drops of 10mg/ml ofcupric sulfate shaking after the addition of eachdrop,A reddish-violet color is produced.
C: lt gives reaction of sulphate.
Conforms
PH5.0-7.55.4
Loss on dryingNMT7.0%3.0%
Residue on ignitionNMT5.0%0.20%
On the dried basisNot less than 6000IU/mg8254IU/mg
Related substancesAny impurityNMT3.0%1.8%
Total impurity17.0%4.1%
Compositionof PolymyxinsB3NMT6.0%1.4%
B1-1NMT15.0%8.1%
Sum of B1,B2,B3 and B1-lNMT80.0%94.0%
ConlusionThe results conform to the standard of USP43
 
 





THERAPEUTIC INDICATIONS

The drug for the treatment of hair loss dwindled.
Finasteride is used to treat symptoms of BPH such as frequent and difficult urination and may reduce the chance of acute urinary retention (sudden inability to urinate). It also may decrease the chance that prostate surgery will be needed.

SHIPPING DETAILS

 
MOQ50G
BY air Any airport in china
By sea Any seaport in china
By courier /



ABOUT US 
HANWEISHI PHARMCHEM CO., LTD. is an import and export company located in Wuhan, which providing comprehensive supply solution for our customers in pharmaceutical and nutraceutical industries. We supply APIs, pharmaceutical intermediates, excipients, natural extracts, and food and feed additives. Our service also includes conducting manufacture audit, applying for regulatory registration, and contract manufacturing.
Since established in 2007, Hanways has developed long term strategic relationships with major manufacturers in China, including Zhejiang Xianju Pharmaceutical Co., Ltd, Zhejiang Guobang Pharmaceutical Co., Ltd and more than 100 others.
HANWEISHI is actively exploring the international market, as well as participating the world CPhI. Nowadays we already have a large number of customers in Southeast Asia, Mid-East, Central and South America, East Europe and African countries.



Scroll to Top